Robert Burns
Stock Analyst at HC Wainwright & Co.
(0.98)
# 3,649
Out of 4,843 analysts
506
Total ratings
25.7%
Success rate
-20%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Robert Burns
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| BNTX BioNTech SE | Reiterates: Buy | $134 | $95.81 | +39.86% | 40 | May 22, 2025 | |
| COGT Cogent Biosciences | Maintains: Buy | $14 → $12 | $5.44 | +120.59% | 11 | May 20, 2025 | |
| YMAB Y-mAbs Therapeutics | Maintains: Buy | $12 → $11 | $4.60 | +139.13% | 21 | May 19, 2025 | |
| BCAX Bicara Therapeutics | Maintains: Buy | $44 → $41 | $9.25 | +343.24% | 4 | May 16, 2025 | |
| HURA TuHURA Biosciences | Reiterates: Buy | $12 | $3.06 | +292.16% | 3 | May 16, 2025 | |
| ELVN Enliven Therapeutics | Maintains: Buy | $39 → $40 | $17.77 | +125.10% | 4 | May 15, 2025 | |
| AVBP ArriVent BioPharma | Maintains: Buy | $39 → $40 | $21.31 | +87.75% | 9 | May 14, 2025 | |
| RVMD Revolution Medicines | Maintains: Buy | $73 → $72 | $39.40 | +82.74% | 20 | May 14, 2025 | |
| ORIC ORIC Pharmaceuticals | Maintains: Buy | $21 → $22 | $8.17 | +169.28% | 24 | May 9, 2025 | |
| CRDF Cardiff Oncology | Maintains: Buy | $17 → $18 | $3.41 | +427.86% | 2 | May 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $5 | $0.89 | +464.40% | 16 | May 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $74 → $47 | $46.72 | +0.61% | 32 | Apr 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $9 → $3 | $1.06 | +183.02% | 14 | Apr 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $13 | $2.22 | +485.59% | 12 | Apr 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $36 | $10.63 | +238.66% | 15 | Apr 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $10 | $7.21 | +38.70% | 7 | Apr 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $8 | $3.09 | +158.90% | 21 | Mar 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $10 | $2.57 | +289.11% | 3 | Mar 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $40 | $43.04 | -7.06% | 7 | Mar 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $4 → $2 | $1.38 | +44.93% | 21 | Mar 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $5 | $0.88 | +469.35% | 11 | Mar 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $9 → $8 | $1.17 | +583.76% | 17 | Mar 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $11 → $12 | $2.20 | +445.45% | 13 | Mar 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $40 → $34 | $2.53 | +1,243.87% | 3 | Mar 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $12 → $13 | $11.43 | +13.74% | 20 | Mar 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $11 → $10 | $2.12 | +371.70% | 14 | Mar 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $10 → $5 | $1.38 | +262.32% | 18 | Mar 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $16 | $3.00 | +433.33% | 21 | Mar 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $21 → $22 | $8.98 | +144.99% | 16 | Feb 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $7 | $2.34 | +199.15% | 7 | Feb 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $4.23 | - | 4 | Jan 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | n/a | $7.80 | - | 13 | Jan 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $12 → $11 | $1.27 | +766.14% | 13 | Sep 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $2.25 | $0.68 | +233.33% | 10 | Aug 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $500 → $200 | $6.10 | +3,178.69% | 5 | May 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $110 → $20 | $0.35 | +5,609.39% | 2 | Mar 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $8.04 | - | 6 | Jan 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $150 | $2.59 | +5,691.51% | 6 | Aug 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $22 | $1.19 | +1,748.74% | 4 | Mar 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $115 → $7 | $1.21 | +478.51% | 7 | Jan 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $12 → $11 | $2.65 | +315.09% | 1 | Dec 22, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $250 → $225 | $0.04 | +637,293.77% | 7 | Nov 24, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Buy | $25 | $3.81 | +555.74% | 1 | Jun 21, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $19 → $13 | $1.75 | +642.86% | 1 | Jan 7, 2021 |
BioNTech SE
May 22, 2025
Reiterates: Buy
Price Target: $134
Current: $95.81
Upside: +39.86%
Cogent Biosciences
May 20, 2025
Maintains: Buy
Price Target: $14 → $12
Current: $5.44
Upside: +120.59%
Y-mAbs Therapeutics
May 19, 2025
Maintains: Buy
Price Target: $12 → $11
Current: $4.60
Upside: +139.13%
Bicara Therapeutics
May 16, 2025
Maintains: Buy
Price Target: $44 → $41
Current: $9.25
Upside: +343.24%
TuHURA Biosciences
May 16, 2025
Reiterates: Buy
Price Target: $12
Current: $3.06
Upside: +292.16%
Enliven Therapeutics
May 15, 2025
Maintains: Buy
Price Target: $39 → $40
Current: $17.77
Upside: +125.10%
ArriVent BioPharma
May 14, 2025
Maintains: Buy
Price Target: $39 → $40
Current: $21.31
Upside: +87.75%
Revolution Medicines
May 14, 2025
Maintains: Buy
Price Target: $73 → $72
Current: $39.40
Upside: +82.74%
ORIC Pharmaceuticals
May 9, 2025
Maintains: Buy
Price Target: $21 → $22
Current: $8.17
Upside: +169.28%
Cardiff Oncology
May 9, 2025
Maintains: Buy
Price Target: $17 → $18
Current: $3.41
Upside: +427.86%
May 5, 2025
Reiterates: Buy
Price Target: $5
Current: $0.89
Upside: +464.40%
Apr 30, 2025
Downgrades: Neutral
Price Target: $74 → $47
Current: $46.72
Upside: +0.61%
Apr 28, 2025
Maintains: Buy
Price Target: $9 → $3
Current: $1.06
Upside: +183.02%
Apr 14, 2025
Reiterates: Buy
Price Target: $13
Current: $2.22
Upside: +485.59%
Apr 2, 2025
Reiterates: Buy
Price Target: $36
Current: $10.63
Upside: +238.66%
Apr 2, 2025
Reiterates: Buy
Price Target: $10
Current: $7.21
Upside: +38.70%
Mar 31, 2025
Reiterates: Buy
Price Target: $8
Current: $3.09
Upside: +158.90%
Mar 31, 2025
Reiterates: Buy
Price Target: $10
Current: $2.57
Upside: +289.11%
Mar 27, 2025
Reiterates: Buy
Price Target: $40
Current: $43.04
Upside: -7.06%
Mar 25, 2025
Maintains: Neutral
Price Target: $4 → $2
Current: $1.38
Upside: +44.93%
Mar 20, 2025
Reiterates: Buy
Price Target: $5
Current: $0.88
Upside: +469.35%
Mar 19, 2025
Maintains: Buy
Price Target: $9 → $8
Current: $1.17
Upside: +583.76%
Mar 18, 2025
Maintains: Buy
Price Target: $11 → $12
Current: $2.20
Upside: +445.45%
Mar 18, 2025
Maintains: Buy
Price Target: $40 → $34
Current: $2.53
Upside: +1,243.87%
Mar 10, 2025
Maintains: Neutral
Price Target: $12 → $13
Current: $11.43
Upside: +13.74%
Mar 10, 2025
Maintains: Buy
Price Target: $11 → $10
Current: $2.12
Upside: +371.70%
Mar 7, 2025
Maintains: Buy
Price Target: $10 → $5
Current: $1.38
Upside: +262.32%
Mar 7, 2025
Reiterates: Buy
Price Target: $16
Current: $3.00
Upside: +433.33%
Feb 13, 2025
Maintains: Buy
Price Target: $21 → $22
Current: $8.98
Upside: +144.99%
Feb 10, 2025
Reiterates: Buy
Price Target: $7
Current: $2.34
Upside: +199.15%
Jan 30, 2025
Downgrades: Neutral
Price Target: n/a
Current: $4.23
Upside: -
Jan 28, 2025
Reiterates: Neutral
Price Target: n/a
Current: $7.80
Upside: -
Sep 5, 2024
Maintains: Neutral
Price Target: $12 → $11
Current: $1.27
Upside: +766.14%
Aug 19, 2024
Reiterates: Buy
Price Target: $2.25
Current: $0.68
Upside: +233.33%
May 8, 2024
Maintains: Buy
Price Target: $500 → $200
Current: $6.10
Upside: +3,178.69%
Mar 21, 2024
Maintains: Buy
Price Target: $110 → $20
Current: $0.35
Upside: +5,609.39%
Jan 8, 2024
Downgrades: Neutral
Price Target: n/a
Current: $8.04
Upside: -
Aug 8, 2023
Reiterates: Buy
Price Target: $150
Current: $2.59
Upside: +5,691.51%
Mar 17, 2023
Reiterates: Buy
Price Target: $22
Current: $1.19
Upside: +1,748.74%
Jan 24, 2023
Downgrades: Neutral
Price Target: $115 → $7
Current: $1.21
Upside: +478.51%
Dec 22, 2021
Maintains: Buy
Price Target: $12 → $11
Current: $2.65
Upside: +315.09%
Nov 24, 2021
Maintains: Buy
Price Target: $250 → $225
Current: $0.04
Upside: +637,293.77%
Jun 21, 2021
Assumes: Buy
Price Target: $25
Current: $3.81
Upside: +555.74%
Jan 7, 2021
Maintains: Buy
Price Target: $19 → $13
Current: $1.75
Upside: +642.86%